Gene therapy for hemophilia

Authors

Sylvia Fong (ORCID: https://orcid.org/0000-0002-3818-4146)
Peter J. Lenting (ORCID: https://orcid.org/0000-0002-7937-3429)

Institutions

Inserm (FR)
Université Paris-Saclay (FR)
BioMarin (United States) (US)

Publication Details

Journal: Blood Advances
Published: 2024-10-08
DOI: https://doi.org/10.1182/bloodadvances.2024013864
Citations: 3
Primary Topic: Virus-based gene therapy research
Type: article
Field-Weighted Citation Impact: 1.65

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Gene therapy for hemophilia

Sylvia Fong, Peter J. Lenting

Oct 8, 2024

3 citations

Blood Advances

Virus-based gene therapy research

1.65

article

Gene therapy for hemophilia

Sylvia Fong, Peter J. Lenting

October 8, 2024article en

3 citations

Abstract

No abstract available for this paper.

Blood AdvancesVol. 8(23)

Inserm (FR), Université Paris-Saclay (FR), BioMarin (United States) (US)

Openalex Percentile: Top 15%

Virus-based gene therapy research

1.65

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Gene therapy for hemophilia — Sylvia Fong, Peter J. Lenting · Blood Advances (2024) | TGRS Research Map | TGRS